← European Medicine Shortage Tracker · all medicines

Ziprasidone shortage — availability across Europe

Ziprasidone currently has availability issues reported in 4 European registers: Austria, Spain, Ireland, Sweden.

MEDICALLY REVIEWED
Dr. Chrysoula I. Liakou MD, PhD
Internal Medicine Specialist
Cancer Immunology Researcher
Reviewed 30 July 2026 · next review due 30 January 2027

Shortage  ATC — · also listed as: ZIPRASIDON MESILAT TRIHYDRAT · ZIPRASIDONHYDROCHLORID · ZIPRASIDONA · Ziprasidone · ziprasidonhydrokloridmonohydrat · data refreshed 7 August 2026

Key facts

As of 7 August 2026, 4 of the 10 tracked registers list current availability issues for Ziprasidone, covering 8 affected product presentations. The longest-running open report was filed in Sweden on 2026-03-09 and has now been open for about 5 months. Where agencies state a cause, manufacturing problems lead with 1 of the 1 stated-cause reports. The furthest expected-resolution date currently on file is 2027-03-22; the earliest is 2026-08-25. Momentum is current, not historical: 4 of the open reports were filed within the last 90 days. Registers in Spain, Ireland, Sweden indicate that alternatives or equivalents are available — a pharmacist or doctor can advise on switching.

WhereStatus & productsSinceExpected end Reason / alternativesSource
🇦🇹 AustriaShortage
Zeldox 20 mg/ml - Pulver zur Herstellung einer Injektionslösung
+ 2 more products
Zeldox 40 mg - Hartkapseln
Zeldox 60 mg - Hartkapseln
2026-03-23register ↗
🇪🇸 SpainShortage
ZIPRASIDONA SANDOZ 60 MG CAPSULAS DURAS EFG 56 cápsulas
+ 1 more products
ZIPRASIDONA VIATRIS 40 mg CAPSULAS DURAS EFG, 56 cápsulas
2026-03-102027-03-22Existen otros medicamentos con el mismo principio activo y misma vía.
Alternatives: Existe/n otro/s medicamento/s con el mismo principio activo y para la misma vía de administración.
register ↗
🇮🇪 IrelandShortage
Geodon 80mg capsules, hard
2026-05-112026-09-30Manufacturing delay (Multiple countries)
Alternatives: Alternative(s) available — see the national register.
register ↗
🇸🇪 SwedenShortage
Ziprasidon STADA 60 mg Kapsel, hård
+ 1 more products
Ziprasidon STADA 80 mg Kapsel, hård
2026-03-092026-09-30
Alternatives: Alternative(s) available — see the national register.
register ↗

New register reports per month

2026-03: 32026-04: 02026-05: 32026-06: 02026-07: 22026-032026-07

Full report history (8 register entries)

Every individual register entry for Ziprasidone in the tracked sources, newest first — including resolved and discontinued reports.

Reg.ProductStatusReportedExpected endStated reason
🇦🇹 ATZeldox 60 mg - HartkapselnShortage2026-07-29
🇦🇹 ATZeldox 40 mg - HartkapselnShortage2026-07-10
🇮🇪 IEGeodon 80mg capsules, hardShortage2026-05-112026-09-30Manufacturing delay (Multiple countries)
🇪🇸 ESZIPRASIDONA SANDOZ 60 MG CAPSULAS DURAS EFG 56 cápsulasShortage2026-05-102026-08-25Existen otros medicamentos con el mismo principio activo y m
🇸🇪 SEZiprasidon STADA 60 mg Kapsel, hårdShortage2026-05-062026-09-30
🇦🇹 ATZeldox 20 mg/ml - Pulver zur Herstellung einer InjektionslösungShortage2026-03-23
🇪🇸 ESZIPRASIDONA VIATRIS 40 mg CAPSULAS DURAS EFG, 56 cápsulasShortage2026-03-102027-03-22Existen otros medicamentos con el mismo principio activo y m
🇸🇪 SEZiprasidon STADA 80 mg Kapsel, hårdShortage2026-03-092026-09-30

Frequently asked

Is Ziprasidone currently in shortage in Europe?

Yes. As of 7 August 2026, availability issues are reported in: Austria, Spain, Ireland, Sweden. Availability is national — a shortage in one country does not mean it is short everywhere.

When is the Ziprasidone shortage expected to end?

Agency prognoses on file range from 2026-08-25 to 2027-03-22. These are manufacturer-reported estimates and frequently move; check the linked register entry for the latest date.

Are there alternatives to Ziprasidone?

5 of the active register entries indicate alternatives or equivalents (same active substance or an alternative treatment). Do not switch on your own — a pharmacist or prescriber can confirm the right substitute in your country.

Where does this Ziprasidone availability data come from?

Directly from the official medicines-agency registers that list Ziprasidone: BASG (Austria), AEMPS CIMA (Spain), HPRA (Ireland), Läkemedelsverket (Sweden). Every row on this page links to the underlying official record, and the dataset is refreshed from the primary sources every morning. Cross-language matching groups the same active substance across registers, so national spellings all resolve to this page.

Embed this tracker

Pharmacies, patient sites and newsrooms are welcome to embed the live status of Ziprasidone — free, with attribution. Copy this snippet:

<iframe src="https://www.mobidoctor.eu/medicine-shortages/medicine-shortages/ziprasidone/embed.html" width="100%" height="150" loading="lazy" style="border:1px solid #e1e0d9;border-radius:12px" title="Ziprasidone availability in Europe"></iframe>
<p style="font-size:12px">Source: <a href="https://www.mobidoctor.eu/medicine-shortages/medicine-shortages/ziprasidone/">Ziprasidone shortage status — European Medicine Shortage Tracker</a> by MobiDoctor</p>
Cite: “Ziprasidone: availability status across 4 European registers — European Medicine Shortage Tracker (MobiDoctor), 7 August 2026.” Link this page and the agency record. Statuses come from the linked official registers and can change daily.